About Epineuron
Epineuron is a company based in Hamilton (Canada) founded in 2016 by Mike Willand and Sergio Aguirre. Epineuron offers products and services including PeriPulse™ Nerve Stimulation System. Epineuron operates in a competitive market with competitors including Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Monarch Bioimplants, among others.
- Headquarter Hamilton, Canada
- Founders Mike Willand, Sergio Aguirre
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epineuron Technologies Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Ontario Centre of Innovation
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epineuron
Epineuron offers a comprehensive portfolio of products and services, including PeriPulse™ Nerve Stimulation System.
Delivers electrical stimulation to regenerate damaged nerves.
Funding Insights of Epineuron
Investors in Epineuron
Epineuron has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ontario Centre of Innovation and Ontario Brain Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brain research and care innovation is driven in Ontario.
|
Locked | Locked | Locked | |
|
Research and development services are delivered to an innovation community.
|
Locked | Locked | Locked |
Investor details for Epineuron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epineuron
Investment portfolio details for Epineuron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epineuron
Detailed financials for Epineuron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epineuron Comparisons
Peer comparison for Epineuron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epineuron
Epineuron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Monarch Bioimplants, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| Locked | Locked | Locked |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| Locked | Locked | Locked |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| Locked | Locked | Locked |
Wearable prostheses for sensory peripheral neuropathy patients are developed.
|
|
| Locked | Locked | Locked |
Developer of bioimplant for peripheral nerve repair
|
Detailed competitors of Epineuron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epineuron
Complete news archive for Epineuron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epineuron
Epineuron was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Epineuron is headquartered in Hamilton, Canada. It is registered at Hamilton, Ontario, Canada.
Sergio Aguirre is the current CEO of Epineuron. They have also founded this company.
Epineuron Technologies was founded in 2016 in Hamilton, Canada, within the medical devices sector. Peripheral nerve injuries such as transection, crush, compression, traction, and ischemia are treated through specialized devices. Electrical stimulation of nerves is applied to support natural biochemical processes for healing and repair, addressing resulting physical disabilities. Operations focus on healthcare applications in nerve regeneration.
Epineuron's top competitors include Avation, Tulavi Nerve Therapeutics and RxFunction.
Epineuron offers PeriPulse™ Nerve Stimulation System.
Epineuron has 2 investors. Key investors include Ontario Centre of Innovation, and Ontario Brain Institute.